KA
Kozak & Associates’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
359
+1
| +0.3% | +$346 | 0.03% | 99 |
|
|
2025
Q1 | $158K | Buy |
358
+2
| +0.6% | +$881 | 0.04% | 82 |
|
|
2024
Q4 | $132K | Sell |
356
-29
| -8% | -$10.8K | 0.03% | 93 |
|
|
2024
Q3 | $191K | Buy |
385
+51
| +15% | +$25.4K | 0.05% | 82 |
|
|
2024
Q2 | $177K | Buy |
334
+14
| +4% | +$7.43K | 0.04% | 78 |
|
|
2024
Q1 | $174K | Sell |
320
-188
| -37% | -$102K | 0.05% | 79 |
|
|
2023
Q4 | $241K | Buy |
508
+1
| +0.2% | +$474 | 0.08% | 71 |
|
|
2023
Q3 | $228K | Buy |
507
+1
| +0.2% | +$450 | 0.08% | 74 |
|
|
2023
Q2 | $225K | Buy |
506
+1
| +0.2% | +$444 | 0.09% | 78 |
|
|
2023
Q1 | $232K | Buy |
505
+1
| +0.2% | +$459 | 0.1% | 81 |
|
|
2022
Q4 | $258K | Buy |
504
+1
| +0.2% | +$512 | 0.13% | 72 |
|
|
2022
Q3 | $237K | Buy |
503
+1
| +0.2% | +$471 | 0.15% | 69 |
|
|
2022
Q2 | $242K | Buy |
502
+2
| +0.4% | +$964 | 0.16% | 66 |
|
|
2022
Q1 | $237K | Hold |
500
| – | – | 0.15% | 68 |
|
|
2021
Q4 | $237K | Buy |
500
+60
| +14% | +$28.4K | 0.15% | 68 |
|
|
2021
Q3 | $191K | Buy |
+440
| New | +$191K | 0.11% | 81 |
|